DEF 14A: Know Labs Seeks Stockholder Approval for Share Increase and Equity Incentive Plan Amendment

Know Labs is asking stockholders to vote on proposals to increase the number of authorized common shares and amend the equity incentive plan at a special meeting on October 25, 2024.

Summary

• Know Labs is holding a special meeting of stockholders on October 25, 2024, to vote on three proposals.
• The first proposal seeks approval to amend the Articles of Incorporation to increase the number of authorized common stock shares from 200 million to 300 million.
• The second proposal involves amending the 2021 Equity Incentive Plan to increase the number of shares authorized for issuance under the plan to 40 million, plus additional shares from the 2011 plan.
• The third proposal asks stockholders to approve the adjournment of the Special Meeting in order to solicit additional proxies if there are not sufficient shares to be voted in favor of any of the foregoing proposals at the time of the Special Meeting.
• The Board of Directors unanimously recommends voting FOR all three proposals.
• Stockholders of record as of September 12, 2024, are entitled to vote.
• The proxy materials were first transmitted to stockholders on or about October 7, 2024.

Sentiment

Score: 7

Explanation: The document is generally positive as it outlines measures to provide the company with financial flexibility and incentivize employees, but it also acknowledges potential dilution for existing shareholders.

Positives

• The proposed increase in authorized shares provides the company with flexibility to raise capital for general corporate purposes.
• The amendment to the equity incentive plan is intended to attract, retain, and incentivize employees, directors, consultants, and independent contractors.
• The Board believes that hosting a virtual meeting is in the best interest of the Company and its stockholders.
• The Board of Directors unanimously recommends voting FOR all proposals.

Negatives

• If the company issues additional shares, the ownership interests of current stockholders will be diluted.
• An increase in the number of authorized shares of common stock may also, under certain circumstances, be construed as having an anti-takeover effect.

Risks

• Without an increase in the number of authorized shares of common stock, the company may be constrained in its ability to raise capital.
• If the company issues shares of preferred stock, the shares may have rights, preferences and privileges senior to those of its common stock.
• The company will be required to raise additional capital to execute its business plan.

Future Outlook

The Amendment is intended to give the Company flexibility to issue common stock or securities convertible into common stock for general corporate purposes if an attractive opportunity to do so arises.

Management Comments

• On behalf of the entire Board, thank you for your continued support and investment in Know Labs, Inc.
• After careful consideration, the Board has unanimously approved Proposal1 and Proposal 2, and has determined that they are advisable, fair to and in the best interests of the Company and its stockholders.
• Accordingly, the Board unanimously recommends that stockholders vote FOR the proposals set forth in the accompanying proxy statement.

Industry Context

Companies in growth phases often seek to increase their authorized share count to facilitate future capital raises and incentivize employees through equity compensation.

Comparison to Industry Standards

• Increasing authorized shares is a common practice among publicly traded companies, especially those in the technology and healthcare sectors, to provide flexibility for future financing and strategic opportunities.
• Equity incentive plans are standard tools used by companies to attract and retain talent, aligning employee interests with those of shareholders.

Stakeholder Impact

• Approval of the proposals could impact shareholders through potential dilution but also provide the company with resources for growth.
• Employees, directors, consultants, and independent contractors could benefit from the amended equity incentive plan.
• The company's ability to execute its business plan could impact customers and suppliers.

Next Steps

• Stockholders are encouraged to vote on the proposals before the deadline.
• The company will hold the Special Meeting on October 25, 2024, to discuss and vote on the proposals.

Key Dates

Keywords

proxy statement, stockholders, authorized shares, equity incentive plan, common stock, Know Labs